Skip to main content
. 2015 Mar 30;6(17):15137–15149. doi: 10.18632/oncotarget.3526

Figure 2. PMEPA1 depletion leads to resistance to AR inhibitors.

Figure 2

(A and B) In contrast to control cells, increased percentages to initial cell numbers (2 × 105 cells/6 cm dish) were detected in PMEPA1shRNA harboring LNCaP and VCaP cells in response to enzalutamide (ENZ) treatment at dosages of 10 or 25 μM for 5 or 10 days (p < 0.05).